Search

Search Results
Results 991 - 1000 of 1163 for Diabetes Type II
  • Review outlines effective approaches to reduce recurrent hepatic encephalopathy
    News - 31 Jul 2026
    Hepatic encephalopathy (HE) is a neurologic complication of advanced liver disease, causing impaired functioning, reduced quality of life (QOL), and increased hospitalisation and mortality.
  • Vttack
    Drug - 29 Jun 2026
    Consumer Medicine Information (CMI) about Vttack intended for persons living in Australia.
  • Ramipril Viatris
    Drug - 26 Jun 2026
    Consumer Medicine Information (CMI) about Ramipril Viatris intended for persons living in Australia.
  • Itracap
    Drug - 1 Jun 2026
    Consumer Medicine Information (CMI) about Itracap intended for persons living in Australia.
  • Exerkines Explained: The Exercise Molecules That Prevent Chronic Disease
    Health - 2 Mar 2026
    This article examines how exercise-induced exerkines prevent disease, as well as promote metabolic, cardiovascular, immune, and neurological health.
  • Higher ultra-processed food intake aligns with greater binge eating risk in obesity study
    News - 23 Feb 2026
    Higher intake of ultra-processed foods in adults with obesity was associated with disordered eating symptoms, poorer diet quality, and lower protein intake. The cross-sectional findings suggest...
  • Fenac EC
    Drug - 18 Feb 2026
    Consumer Medicine Information (CMI) about Fenac EC intended for persons living in Australia.
  • Perisyl Combi
    Drug - 9 Dec 2025
    Consumer Medicine Information (CMI) about Perisyl Combi intended for persons living in Australia.
  • Sacubitril/Valsartan Alphapharm
    Drug - 7 Jul 2025
    Consumer Medicine Information (CMI) about Sacubitril/Valsartan Alphapharm intended for persons living in Australia.
  • Cozavan
    Drug - 20 Jun 2025
    Consumer Medicine Information (CMI) about Cozavan intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback